Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Submitted by
admin
on January 7, 2012 - 1:25pm
Source:
Yahoo/MarketWire
News Tags:
Theravance
Astellas
Vibativ
antibiotics
Headline:
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Do Not Allow Advertisers to Use My Personal information
